Astec LifeSciences Limited (NSE:ASTEC) — Stock Price

Rs620.65 INR
▲ 0.02% today

Astec LifeSciences Limited (NSE:ASTEC) is currently trading at Rs620.65 INR, up 0.02% today. Over the past 52 weeks, shares have ranged between Rs521.85 and Rs918.75. This page tracks Astec LifeSciences Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Astec LifeSciences Limited (ASTEC) total market value.

Astec LifeSciences Limited (ASTEC) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Astec LifeSciences Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Astec LifeSciences Limited Income Statement — Revenue, Profit & Earnings by Year

Astec LifeSciences Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs3.81 Billion Rs4.58 Billion Rs6.28 Billion Rs6.77 Billion Rs5.55 Billion
Cost of Revenue Rs2.97 Billion Rs3.25 Billion Rs4.01 Billion Rs3.91 Billion Rs3.45 Billion
Gross Profit Rs-685.16 Million Rs1.33 Billion Rs2.27 Billion Rs2.86 Billion Rs2.10 Billion
Research & Development Rs21.36 Million Rs27.00 Million Rs14.85 Million Rs9.14 Million Rs9.22 Million
SG&A Rs72.26 Million Rs71.36 Million Rs122.56 Million Rs81.42 Million Rs66.04 Million
Total Operating Expenses Rs418.77 Million Rs365.13 Million Rs407.19 Million Rs1.65 Billion Rs248.88 Million
Operating Income Rs-1.10 Billion Rs-403.64 Million Rs450.03 Million Rs1.21 Billion Rs870.09 Million
EBITDA Rs-662.07 Million Rs-2.69 Million Rs893.14 Million Rs1.65 Billion Rs1.19 Billion
EBIT Rs-1.10 Billion Rs-365.22 Million Rs556.62 Million Rs1.30 Billion Rs938.22 Million
Interest Expense Rs366.97 Million Rs252.26 Million Rs207.14 Million Rs90.58 Million Rs47.51 Million
Income Before Tax Rs-1.41 Billion Rs-617.48 Million Rs349.47 Million Rs1.21 Billion Rs890.71 Million
Income Tax Expense Rs-62.77 Million Rs-148.57 Million Rs93.53 Million Rs312.43 Million Rs240.02 Million
Net Income Rs-1.35 Billion Rs-469.30 Million Rs255.65 Million Rs898.59 Million Rs650.49 Million

Astec LifeSciences Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Astec LifeSciences Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs8.81 Billion Rs9.75 Billion Rs9.79 Billion Rs8.97 Billion Rs6.78 Billion
Total Current Assets Rs3.41 Billion Rs3.98 Billion Rs4.99 Billion Rs5.16 Billion Rs3.30 Billion
Cash & Equivalents — — Rs16.84 Million — —
Short-term Investments Rs2.80 Million Rs11.76 Million Rs22.80 Million Rs27.90 Million Rs12.03 Million
Net Receivables Rs1.47 Billion Rs1.69 Billion Rs1.55 Billion Rs2.76 Billion Rs1.87 Billion
Inventory Rs1.60 Billion Rs1.96 Billion Rs2.95 Billion Rs1.87 Billion Rs1.06 Billion
Property, Plant & Equipment Rs4.97 Billion Rs5.32 Billion Rs4.29 Billion Rs3.51 Billion Rs3.23 Billion
Goodwill — — — — —
Total Liabilities Rs6.46 Billion Rs6.05 Billion Rs5.60 Billion Rs5.00 Billion Rs3.68 Billion
Total Current Liabilities Rs3.66 Billion Rs3.97 Billion Rs5.26 Billion Rs4.91 Billion Rs3.22 Billion
Long-term Debt Rs2.80 Billion Rs1.99 Billion Rs108.62 Million Rs0.00 Rs400.00 Million
Net Debt Rs5.52 Billion Rs4.93 Billion Rs3.41 Billion Rs2.79 Billion Rs1.87 Billion
Total Stockholder Equity Rs2.35 Billion Rs3.69 Billion Rs4.19 Billion Rs3.96 Billion Rs3.09 Billion
Retained Earnings Rs1.41 Billion Rs2.76 Billion Rs3.26 Billion Rs3.04 Billion Rs2.17 Billion

Astec LifeSciences Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Astec LifeSciences Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs-83.99 Million Rs102.21 Million Rs746.56 Million Rs236.04 Million Rs-81.62 Million
Capital Expenditures Rs218.22 Million Rs1.35 Billion Rs1.17 Billion Rs1.04 Billion Rs1.03 Billion
Free Cash Flow Rs-302.20 Million Rs-1.25 Billion Rs-426.03 Million Rs-803.74 Million Rs-1.11 Billion
Investing Cash Flow Rs-152.30 Million Rs-1.35 Billion Rs-1.13 Billion Rs-1.04 Billion Rs-731.10 Million
Financing Cash Flow Rs237.33 Million Rs1.25 Billion Rs377.70 Million Rs804.77 Million Rs813.36 Million
Dividends Paid — Rs-29.41 Million Rs29.41 Million Rs29.38 Million Rs29.36 Million
Stock-Based Compensation Rs345.00K Rs3.01 Million Rs3.31 Million Rs1.05 Million Rs99.00K
Depreciation Rs437.14 Million Rs362.53 Million Rs336.52 Million Rs343.56 Million Rs256.55 Million
Change in Cash Rs1.04 Million Rs-19.00K Rs-811.00K Rs2.16 Million Rs307.00K

Astec LifeSciences Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Astec LifeSciences Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 21, 2026 — — —
Jan 26, 2026 — — —
Oct 29, 2025 -11.34 -8.70 -30.34%
Jul 28, 2025 -16.85 -7.30 -130.82%
Apr 30, 2025 — — —
Jan 27, 2025 -20.59 -13.65 -50.84%
Oct 25, 2024 -19.66 -16.45 -19.51%
Jul 29, 2024 -20.26 -10.75 -88.47%